| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Weekly Insider Buys: Biotech & Medical Stocks
Posted on 07/16/2007 18:11:58 | Link | Post Comment
by Hisham S. Ayoub, DMD
BioHealth Investor
Following data represents stock purchases by company insiders during the past week. This report may not be accurate or complete, and readers should not base their investment decisions on the following information.
July 9 - July 13
Advanced Medical Optics (EYE): $34.64 - $34.77 by Beneficial Owner
Biomerica (BMRA): $0.70-$0.75 by Director
Bioenvision (BIVN): $5.60 by Beneficial Owner
Chelsea Therapeutics (CHTP): $6.98 by Beneficial Owner
Cyberonics (CYBX): $16.83-$17.32 by Director
Enzon Pharmaceuticals (ENZN): $7.71-$7.73 by Beneficial Owner
Genaera (GENR): $2.63-$2.81 by Beneficial Owner
Health Systems Solutions (HSSO): $2.00 by Beneficial Owner
Human Genome Sciences (HGSI): $7.59-$8.99 by Officers & Directors
MGT Capital Investments (MGT): $5.00 by Chairman/CEO
Novogen (NVGN): $8.40 by Beneficial Owner
ReGen Biologics (RGBI): $0.38 by Vice President
Zila (ZILA): $1.26-$1.28 by Executive Vice President and Director
BioHealth Investor.com
___________________
BioHealth Investor
Following data represents stock purchases by company insiders during the past week. This report may not be accurate or complete, and readers should not base their investment decisions on the following information.
July 9 - July 13
Advanced Medical Optics (EYE): $34.64 - $34.77 by Beneficial Owner
Biomerica (BMRA): $0.70-$0.75 by Director
Bioenvision (BIVN): $5.60 by Beneficial Owner
Chelsea Therapeutics (CHTP): $6.98 by Beneficial Owner
Cyberonics (CYBX): $16.83-$17.32 by Director
Enzon Pharmaceuticals (ENZN): $7.71-$7.73 by Beneficial Owner
Genaera (GENR): $2.63-$2.81 by Beneficial Owner
Health Systems Solutions (HSSO): $2.00 by Beneficial Owner
Human Genome Sciences (HGSI): $7.59-$8.99 by Officers & Directors
MGT Capital Investments (MGT): $5.00 by Chairman/CEO
Novogen (NVGN): $8.40 by Beneficial Owner
ReGen Biologics (RGBI): $0.38 by Vice President
Zila (ZILA): $1.26-$1.28 by Executive Vice President and Director
BioHealth Investor.com
___________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- e-techblog
- Wishing Wealth
- Financial Skeptic
- Don't Mess With Taxes
- Millionaire Now! by Larry Nusbaum
- 360 Digest
Examples
Morpheus Trading - Thu Jul 17, 2008 01:15AM
NOTE: Please click on the charts below to enlarge them if th [read more]
NOTE: Please click on the charts below to enlarge them if th [read more]
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
The Swing of Things - Thu Jul 17, 2008 09:36AM
I used to make a pretty good living sharing hard won [read more]
I used to make a pretty good living sharing hard won [read more]
<< My Home | TheMoneyBlogs Home